My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Altimmune, Inc. - Common Stock
(NQ:
ALT
)
3.780
-0.090 (-2.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altimmune, Inc. - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
52 Biggest Movers From Yesterday
May 25, 2021
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...
Via
Benzinga
Looking Into Altimmune's Return On Capital Employed
May 17, 2021
During Q1, Altimmune's (NASDAQ:ALT) reported sales totaled $837.52 thousand. Despite a 38.25% in earnings, the company posted a loss of $14.86 million. Altimmune collected $2.31...
Via
Benzinga
ALTIMMUNE INC (ALT) Q1 2021 Earnings Call Transcript
May 17, 2021
ALT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For May 17, 2021
May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...
Via
Benzinga
Altimmune Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
May 11, 2021
On Tuesday, Altimmune stock received a positive adjustment to its Relative Strength Rating, from 78 to 86. The biopharma stock is worth watching.
Via
Investor's Business Daily
Altimmune's Intranasal COVID-19 Vaccine Candidate Shows Sterilizing Immunity After Single Dose
May 10, 2021
Altimmune Inc (NASDAQ: ALT) has announced positive results from a preclinical study evaluating its intranasal COVID-19 vaccine candidate, AdCOVID, in a SARS-...
Via
Benzinga
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
April 10, 2021
The short answer: It depends.
Via
The Motley Fool
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.